Nura Bio
Biotechnology, 161 Oyster Point BLVD Ste 200, South San Francisco, California, 94080, United States, 11-50 Employees
Who is NURA BIO
At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure. Expanding on recent breakthroughs in...
Read More
-
Headquarters: 161 Oyster Point BLVD Ste 200, South San Francisco, California, 94080, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Nura Bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nura Bio
Answer: Nura Bio's headquarters are located at 161 Oyster Point BLVD Ste 200, South San Francisco, California, 94080, United States
Answer: Nura Bio's official website is https://nurabio.com
Answer: Nura Bio's revenue is $1 Million to $5 Million
Answer: Nura Bio's SIC: 2834
Answer: Nura Bio's NAICS: 325412
Answer: Nura Bio has 11-50 employees
Answer: Nura Bio is in Biotechnology
Answer: Nura Bio contact info: Phone number: Website: https://nurabio.com
Answer: At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure. Expanding on recent breakthroughs in crucial neurodegenerative pathways, we are positioned to deliver transformative neuroprotective therapies to prevent and protect against neuronal loss and related neuroimmune dysregulation. Our research and development strategy is currently centered on two approaches: prevention of neuronal loss to preserve neurological function; and restoring the function of the neuron-glia axis to improve the nervous systems immune surveillance capacity in response to neurological injury. Our discovery engine and emerging multi-target pipeline spans these approaches and is well positioned to address a broad range of neurological diseases. Nura Bios lead program is the SARM1 inhibitor program. SARM1, has recently emerged an axon-intrinsic metabolic sensor that is a pivotal driver of axonal degeneration and neuronal integrity. Axon degeneration is an early event in several neurological disorders, and halting it early has tremendous potential in the treatment of central, peripheral, and ocular neurological diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month